Sign In
Buy MDT
$77.95
+4.20 (+5.69%)
At Close: Jun 03, 2026
Stay Ahead of the Game With Medtronic (MDT) Q2 Earnings: Wall Street's Insights on Key Metrics
10:15am, Thursday, 13'th Nov 2025
Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth
08:56am, Wednesday, 12'th Nov 2025
Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.
Allworth Financial LP Buys 8,048 Shares of Medtronic PLC $MDT
03:42am, Wednesday, 12'th Nov 2025
Allworth Financial LP lifted its position in Medtronic PLC (NYSE: MDT) by 21.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund
Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA
01:00am, Wednesday, 12'th Nov 2025
ANTWERP, Belgium--(BUSINESS WIRE)--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.
Medtronic: Possible Earnings Beat Incoming But Still Overvalued
04:04pm, Tuesday, 11'th Nov 2025
Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing and limited expansion prospects. MDT's product pipeline, especially in cardiovasc
Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
09:45am, Tuesday, 11'th Nov 2025
Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it.
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
09:00am, Tuesday, 11'th Nov 2025
NEW HOPE, Pa., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologie
Medtronic (MDT) Laps the Stock Market: Here's Why
06:46pm, Friday, 07'th Nov 2025
Medtronic (MDT) closed the most recent trading day at $92.2, moving +2.38% from the previous trading session.
Medtronic to announce financial results for its second quarter of fiscal year 2026
05:43pm, Wednesday, 05'th Nov 2025
GALWAY, Ireland , Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025
2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon
05:15am, Tuesday, 04'th Nov 2025
Long-term investors shouldn't overlook this top pharma stock and top medical device maker. AbbVie is seeing impressive growth from both its immunology portfolio and neuroscience products.
Orchestra BioMed to Host Business Update Call on November 12, 2025
08:00am, Monday, 03'rd Nov 2025
NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologie
Best Dividend Aristocrats For November 2025
10:25am, Saturday, 01'st Nov 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW
Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland , Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology,
Intuitive Surgical vs. Medtronic: Which Stock Is the Better Buy?
08:40am, Monday, 27'th Oct 2025
Intuitive Surgical is the market leader in robotic surgery systems, and has ample growth prospects. Medtronic has a diversified business, some growth opportunities, and a fantastic dividend record.
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
05:24pm, Sunday, 26'th Oct 2025
Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplic
